KEERTHAN SOMANATH: Open Payments
NPI 1578941415 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,707 in 56 payments from 7 companies in 2025. Trend: 2023 $185 · 2024 $1,665 · 2025 $23,707
Speaker / faculty: $19,170Food & beverage: $1,953Travel & lodging: $1,622Consulting: $963
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 40 | $22,264 |
| Brainsway USA INC | 1 | $963 |
| Neurocrine BioSciences, Inc. | 3 | $219 |
| ABBVIE INC. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Alkermes, Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
Products named: SPRAVATO, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA, UZEDY.
Industry payments across CA — which companies pay providers there.
